NFE2L2 and nervous system disorder: The enhanced OS causes the suppression of endogenous ROS regulators and their associated genes, such as nuclear factor-erythroid factor 2-related factor 2 (Nrf2), which has been considered as a master transcription factor of antioxidant mechanisms and has become an attractive therapeutic target for the management of various neurological diseases [9].